Skip to main content

Table 3 Multivariate analysis for survival outcome

From: Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer

Characteristic PFS OS
HR (95% CI) P-value HR (95% CI) P-value
Age, y (> 45 vs. ≤ 45) 0.774 (0.454–1.318) 0.345 0.986 (0.542–1.796) 0.964
Maximum tumor diameter 1.379 0.264 2.023 0.021
 (> 40 mm vs. ≤ 40 mm) (0.785–2.422)   (1.114–3.672)  
Histology 0.832 0.695 0.440 0.045
 (SCC vs. non-SCC) (0.331–2.087)   (0.197–0.982)  
Pre-RT hemoglobin (g/L) 0.654 0.100 0.788 0.406
 (> 110 vs. ≤ 110) (0.394–1.084)   (0.449–1.383)  
Treatment     
 Surgery + adjuvant RT 1.441 0.170 1.466 0.195
 vs. radical RT (0.856–2.428)   (0.822–2.615)  
  1. PFS: progression-free survival; OS: overall survival; HR: hazard ratio, 95% CI: 95% confidence interval, SCC: squamous cell carcinoma, RT: radiotherapy.